Candida albicans Skin Test Antigen for Cellular Hypersensitivity (Candin)
Candida albicans Skin Test Antigen for Cellular Hypersensitivity is an FDA-licensed reference biologic from Nielsen Bioscience, Inc. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1995
Reference approved
Reference product
Candin Candida albicans Skin Test Antigen for Cellular Hypersensitivity
Nielsen Bioscience, Inc
- Approved
- Nov 27, 1995
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Candida albicans Skin Test Antigen for Cellular Hypersensitivity, in chronological order.
Reference approval
Approval date of the reference Candida albicans Skin Test Antigen for Cellular Hypersensitivity product.
30 yr 11 mo ago
Frequently asked questions
Are there biosimilars approved for Candida albicans Skin Test Antigen for Cellular Hypersensitivity (Candin)?
No 351(k) biosimilars or interchangeable biosimilars referencing Candida albicans Skin Test Antigen for Cellular Hypersensitivity are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.